Expired
Lead Plaintiff Deadline
Nov 28, 2022
Choose your preferred way to stay informed of new case launches and settlement deadlines
(i) the Company's product, lixivaptan, was less safe than defendants had represented; (ii) defendants overstated lixivaptan’s clinical and commercial prospects; (iii) another Centessa product, ZF874, was less safe than defendants had represented; (iv) defendants overstated ZF874’s clinical and commercial prospects while downplaying the drug’s safety issues; and (v) as a result, documents issued in connection with Centessa's initial public offering and the Company’s public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.
In order to be eligible to join the CNTA class action lawsuit, you must have incurred a loss on shares of Centessa purchased during the class period listed above.
If you suffered a loss in Centessa during the relevant time frame, you have until November 28, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP
